300436 Fujian Cosunter Pharmaceutical
- 15.18
- -0.39-2.50%
About Fujian Cosunter Pharmaceutical Company
The company was founded in 2001 and is a national key high-tech enterprise listed on the Shenzhen Stock Exchange. The company has a national enterprise technology center and has been continuously rated as a model enterprise for national intellectual property advantages for many years; at the same time, it has established companies for innovative drugs, APIs, and proprietary Chinese medicines. Adhering to the corporate mission of “broadcasting benevolence and focusing on people's livelihood”, the company firmly believes in the dream of providing scientific solutions for human liver health, unswervingly promotes innovative drug research and development, implements innovative development strategies, and is committed to fighting the coronavirus, hepatitis B, liver cancer, and liver fibrosis, creating innovative drugs belonging to the Chinese people, and contributing core strength to the innovation and development of independent and controllable drugs in China. The company's main products: anti-hepatitis B virus drugs, hepatoprotective drugs, men's health drugs, cardiovascular drugs, etc. Corporate honors: China Patent Excellence Award; High-tech Enterprise Certificate; Second Prize of Fujian Patent Award; Third Prize of Fujian Science and Technology Progress Award, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- guoping li
- Chairman, Directors, General Manager, Member of the Remuneration and Assessment Committee, Chairman of the Strategy Committee
- 1.20M
- liqing ye
- Directors, Audit Committee Member
- --
- chenming zhuang
- Directors, Deputy General Manager
- --
- guodong li
- Directors, Audit Committee Member, Member of the Strategy Committee, Nomination Committee Members
- 423.60K
- hongming li
- directors, Chief Operating Officer (COO)
- 1.85M
- fuhu huang
- Directors, Deputy General Manager, Member of the Strategy Committee
- 1.58M
- hongjun wu
- Independent Directors, Chairman of the Remuneration and Assessment Committee, Chairman of the Audit Committee
- --
- feimei wu
- Independent Directors, Nomination Committee Members, Member of the Remuneration and Assessment Committee, Audit Committee Member
- --
- fengmin lu
- Independent Directors, Audit Committee Member, Member of the Strategy Committee, Chairman of the Nomination Committee
- --
- qinghe zhang
- Board Secretary, Deputy General Manager
- 481.30K
- shijun wu
- Securities Affairs Representative
- --
- baoming shi
- Chairman of the Supervisory Board, Auditors
- --
- xiaoyang guo
- Auditors
- --
- bingxiang ceng
- Deputy General Manager
- 549.60K
- jianhui guan
- Chief Financial Officer
- 790.70K
- meixiang lu
- Head of Audit
- --
- weizhong mao
- Chief Development Officer, Chief Scientist
- 1.98M
- haifeng lin
- Employee Supervisors
- 303.60K
Analysis
Price Target
No Data
